← Leaderboards
Shailesh Singh
Morehouse School Of Medicine
$6,393,124
Attributed
$7,552,077
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,552,077 · 9
By mechanism
U54$2,223,669 · 3
SC1$1,768,750 · 1
R01$1,738,430 · 1
U01$821,985 · 1
R41$665,320 · 2
R21$333,923 · 1
Top collaborators
- Brian M. Rivers3 shared
- Rajesh Singh3 shared
Most similar at Morehouse School Of Medicine
Same institution · by research overlap
- Clayton Yates$11,417,167
Others in their field
Top investigators on “Cancer Health Disparity”
- William J. Blot · Vanderbilt University$70,788,193
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$69,672,104
- Electra D. Paskett · Ohio State University$66,400,538
- Loic Le Marchand · University Of Hawaii At Manoa$49,268,448
- Lynne I. Wagner · Northwestern University At Chicago$46,776,862
- Valerie C. Montgomery-Rice · Meharry Medical College$45,992,566
Research focus
Cancer Health DisparityMalignant NeoplasmsMalignant Neoplasm Of ProstatePathway InteractionsResponseSerumLaboratoriesBaseTumorIncidenceMediatingCellsApoptosisLigandsSamplingChemokineMolecularTherapeutic TargetChemokine ReceptorLinkLuciferasesDesignNeoplasm MetastasisTumor Growth
Grant awards (27)
The interplay of social and molecular determinants in lung cancer disparity$589,299
R01 · FY2025 · CA · contact PI
Research Education Core$146,726
U54 · FY2025 · CA · contact PI
The interplay of social and molecular determinants in lung cancer disparity$559,834
R01 · FY2024 · CA · contact PI
Research Education Core$194,530
U54 · FY2024 · CA · contact PI
Research Education Core$222,205
U54 · FY2023 · CA · contact PI
The interplay of social and molecular determinants in lung cancer disparity$589,297
R01 · FY2022 · CA · contact PI
Research Education Core$222,205
U54 · FY2022 · CA · contact PI
Research Education Core$226,739
U54 · FY2021 · CA · contact PI
Research Education Core$147,459
U54 · FY2020 · CA · contact PI
Research Education Core$268,092
U54 · FY2019 · CA · contact PI
Research Education Core$272,681
U54 · FY2018 · CA · contact PI
Role of CCL25-CCR9 in Prostate Cancer$353,750
SC1 · FY2017 · CA · contact PI
Anti-CCL25 mAb to treat castration resistant prostate cancer$350,000
R41 · FY2017 · CA · contact PI
Research Education Core$274,796
U54 · FY2017 · CA · contact PI
Role of chemokine receptor in disparities associated with prostate cancer progres$95,778
U01 · FY2017 · CA · contact PI
Role of CCL25-CCR9 in Prostate Cancer$353,750
SC1 · FY2016 · CA · contact PI
Research Education Core$248,236
U54 · FY2016 · CA · contact PI
Role of chemokine receptor in disparities associated with prostate cancer progres$124,223
U01 · FY2016 · CA · contact PI
Role of CCL25-CCR9 in Prostate Cancer$353,750
SC1 · FY2015 · CA · contact PI
Anti-CXCL13 mAb to mitigate prostate cancer health disparities$315,320
R41 · FY2015 · MD · contact PI
Role of chemokine receptor in disparities associated with prostate cancer progres$183,852
U01 · FY2015 · CA · contact PI
Role of CCL25-CCR9 in Prostate Cancer$353,750
SC1 · FY2014 · CA · contact PI
Role of chemokine receptor in disparities associated with prostate cancer progres$205,882
U01 · FY2014 · CA · contact PI
Prostate Cancer Chemoprevention using a Natural Agent$149,265
R21 · FY2014 · CA · contact PI
Role of CCL25-CCR9 in Prostate Cancer$353,750
SC1 · FY2013 · CA · contact PI
Role of chemokine receptor in disparities associated with prostate cancer progres$212,250
U01 · FY2013 · CA · contact PI
Prostate Cancer Chemoprevention using a Natural Agent$184,658
R21 · FY2013 · CA · contact PI